Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, May 14, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Tags
Trastuzumab deruxtecan
Tag:
trastuzumab deruxtecan
Latest Pharma-News
AstraZeneca and Daiichi Sankyo’s Enhertu met prespecified criteria for objective response rate and duration of response
admin
-
March 6, 2023
0
Latest Pharma-News
Enhertu approved in EU for patients with previously treated HER2-positive advanced gastric cancer
admin
-
December 20, 2022
0
Latest Pharma-News
AZ and Daiichi Sankyo’s Enhertu improved progression-free survival by 22 months vs.T-DM1
admin
-
December 8, 2022
0
Latest Pharma-News
Enhertu approved in EU for HER2-positive metastatic breast cancer
admin
-
January 20, 2021
0
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025